The "disruptive therapy" for cancer, China's innovative drug's "DeepSeek moment"! The core keyword

Retrieved on: 2025-08-31 12:22:29

Tags for this article:

Clusters of differentiation

Antineoplastic drugs

Orphan drugs

Cancer immunotherapy

Immune system

Programmed cell death protein 1

Bispecific monoclonal antibody

Ivonescimab

China

Click the tags to see associated articles and topics

The "disruptive therapy" for cancer, China's innovative drug's "DeepSeek moment"! The core keyword. View article details on hiswai:

Excerpt

... antibody drugs in 2027-28, the strong antitumor efficacy of these drugs, and the expiration of patents for monoclonal antibodies. For the Chinese ...

Article found on: news.futunn.com

View Original Article